Lv52
1020 积分 2025-01-04 加入
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
2个月前
已完结
Pembrolizumab for locally advanced cervical cancer – Authors' reply
2个月前
已关闭
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
2个月前
已完结
Long-term Follow-up Results of a Multi-institutional Phase 2 Study of Concurrent Chemoradiation Therapy for Locally Advanced Cervical Cancer in East and Southeast Asia
3个月前
已关闭
Long-term follow-up results of a multi-institutional phase 2 study of concurrent chemoradiation therapy for locally advanced cervical cancer in east and southeast Asia
3个月前
已关闭
Advances in the management of radiation-induced cystitis in patients with pelvic malignancies
3个月前
已完结
The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions
8个月前
已完结
FLASH radiotherapy: A new milestone in the field of cancer radiotherapy
8个月前
已完结
皖公网安备34019202002308
